알림

Clover Health Investments... (CLOV)

NasdaqGS: CLOV · 실시간 가격 · USD

4.23

-0.05 (-1.17%)

종가 기준: Aug 18, 2026, 3:59 PM

-1.17% (1D)

매수호가	3.06
시가총액	2.23B
매출 (ttm)	2.48B
순이익 (ttm)	-18.36M
베타	2.48
EPS (ttm)	-0.05
P/E (ttm)	n/a
선행 P/E	27.93
P/B (ttm)	5.89
P/S (ttm)	0.90
Earnings Date	Nov 4, 2025

매도호가	4.24
거래량	3,395,427
평균 거래량 (20일)	6,769,931
시가	4.25
전일 종가	4.28
일중 범위	4.21 - 4.35
52주 범위	1.58 - 5.59
애널리스트	Buy
목표주가	5 (18.20%)
배당	n/a
배당락일	n/a

CLOV 소개

Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It also operates Clover Assistant, a software platform for physicians to detect, identify, and manage chronic diseases. The company was founded in 2014 and is based in Wilmington, Delaware....

[더 보기]

산업 Healthcare Plans

섹터 Healthcare

IPO 일자 Jun 12, 2020

직원 수 724

상장 거래소 NasdaqGS

티커 CLOV

웹사이트 https://www.cloverhealth.com

전체 기업 정보

재무 실적

2025년 Clover Health Investments의 매출은 1.92B로, 전년 1.37B 대비 40.34% 증가했습니다. 순이익은 -85.55M로, 98.91% 증가했습니다.

재무제표

애널리스트 전망

애널리스트 3명의 투자의견을 종합하면 CLOV 주식의 평균 등급은 "Buy"입니다. 12개월 목표주가는 5로, 최근 주가 대비 18.2% 상승 여력입니다.

주가 전망

어닝 서프라이즈

Clover Health Investments가 Aug 5, 2026에 분기 실적을 발표했습니다:

매출 $743.17M 예상치 하회 $0, 및 55.60% 전년 대비 성장.

EPS 0.07 예상치 상회 0.02, 및 40.00% 전년 대비 성장.

다음 실적 발표

Clover Health Investments Corp.의 실적 발표 예정일은 Nov 4, 2025, 장 마감 후입니다.
애널리스트 예상 매출은 ... 업그레이드

뉴스

4일 전 · Simply Wall St.

Is Clover Health Investments (CLOV) Fairly Valued After A 228% Run?

Clover Health Investments has delivered a very strong 227.7% return over the past 3 years, yet the share price around US$4.49 now lines up with valuation checks that suggest the stock no longer looks ...

5일 전 · Simply Wall St.

Does Clover’s Profit Turn and Raised 2026 Guidance Reshape the Bull Case for CLOV?

Clover Health Investments, Corp. has already reported its second-quarter 2026 results, posting revenue of US$743.17 million versus US$477.62 million a year earlier and moving from a net loss of US$10....

5일 전 · StockStory

The 5 Most Interesting Analyst Questions From Clover Health’s Q2 Earnings Call

Clover Health’s second quarter results were met with a positive market reaction, driven by strong Medicare Advantage membership growth and improved profitability. Management credited the quarter’s per...

6일 전 · Motley Fool

Clover Health (CLOV) Q2 2026 Earnings Call Transcript

Medicare Advantage membership surged 48% as profitability improved sharply.

1주 전 · MarketBeat

Clover Health Eyes 2026 GAAP Profit as AI Platform Fuels Medicare Advantage Growth

Clover Health Investments (NASDAQ:CLOV) is positioning its Medicare Advantage model around earlier identification and treatment of chronic conditions, Interim Chief Financial Officer Clay Thornton sai...

2 페이지 중 1